FYERS
Medico Intercontinental25.90
-0.59 (-2.23%)

Medico Intercontinental Share Price

25.90-0.59 (-2.23%)
-31.91% past 1 Year

Corporate filings & documents

Announcements

Newspaper Publication
2 weeks ago
Newspaper Publication
2 weeks ago
Notice of the 42nd Annual General Meeting of the Company to be held on 30th September 2026.
2 weeks ago
Notice of the 42nd Annual General Meeting of the Company to be held on 30th September 2026.
2 weeks ago
Reg. 34(1) Annual Report
2 weeks ago
Reg. 34(1) Annual Report
2 weeks ago
Intimation of Book closure & Annual General Meeting
2 weeks ago
Intimation of Book closure & Annual General Meeting
2 weeks ago
Announcement under Regulation 30 (LODR) - Newspaper Publication
1 month ago
Announcement under Regulation 30 (LODR) - Newspaper Publication
1 month ago
Results for the Quarter ended 30 June 2026
1 month ago
Results for the Quarter ended 30 June 2026
1 month ago
Pursuant to provisions of Regulation 30 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 14 2026 inter alia considered and approved the matters as mentioned in enclosed file.
1 month ago
Pursuant to provisions of Regulation 30 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 14 2026 inter alia considered and approved the matters as mentioned in enclosed file.
1 month ago
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2026 and any other business items as per agenda circulated.
1 month ago
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2026 and any other business items as per agenda circulated.
1 month ago
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
2 months ago
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
2 months ago
Closure of Trading Windo
2 months ago
Closure of Trading Windo
2 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Shah & PACs
2 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Shah & PACs
2 months ago
Submission of Disclosure
2 months ago
Submission of Disclosure
2 months ago
Newspaper Publication
4 months ago
Newspaper Publication
4 months ago
Intimation of Re-appointment of an Internal Auditors.
4 months ago
Intimation of Re-appointment of an Internal Auditors.
4 months ago
Results for the quarter and financial year ended March 31 2026
4 months ago
Results for the quarter and financial year ended March 31 2026
4 months ago
Outcome of Board meeting dated May 22 2026.
4 months ago
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended March 31 2026 and any other business items as per agenda circulated.
4 months ago
Annual Secretarial Compliance Report under Regulation 24A of the SEBI (LODR) Regulations 2015 for the financial year ended 31st March 2026.
5 months ago
Annual Secretarial Compliance Report under Regulation 24A of the SEBI (LODR) Regulations 2015 for the financial year ended 31st March 2026.
5 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Medico Intercontinental Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24100GJ1984PLC111413</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>18.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PUNEETA SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 08/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months ago
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
5 months ago
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
5 months ago
Closure of Trading Window
5 months ago
Closure of Trading Window
5 months ago
Newspaper Publication
7 months ago
Results for the quarter and nine months ended December 31 2025.
7 months ago
Results for the quarter and nine months ended December 31 2025
7 months ago
Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended December 31 2025 and any other business items as per agenda circulated.
7 months ago
Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
8 months ago
Closure of Trading Window
8 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Dilipkumar Shah & PACs
8 months ago
Submission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations 2015
8 months ago
Announcement under Regulation 30 (LODR) - Newspaper Publication
10 months ago
Results - Financial results for the quarter and half year ended September 30 2025
10 months ago
Outcome of Board meeting held on November 14 2025
10 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Medico Intercontinental Ltd Share Price Today

The Medico Intercontinental Ltd share price today is ₹26.27. During the trading session, the Medico Intercontinental Ltd share price opened at ₹26.27 and recorded an intraday high of ₹26.27 and a low of ₹26.27. Last closing price was ₹26.27. Over the past 52 weeks, the Medico Intercontinental Ltd share price has ranged between ₹20.61 and ₹43.00. The current Medico Intercontinental Ltd stock price reflects real-time market activity based on executed trades on the exchange.